Cargando…

AB162. Prognostic and predictive value of epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma

OBJECTIVE: Prognostic epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma (UTUC) are inconclusive. We conducted this study to identify gene promoter (ABCC6, BRCA1, CDH1, GDF15, HSPA2, RASSF1A, SALL3, THBS1, TMEFF2 and VIM) methylation status and clinical predictors for UTU...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Gengyan, Liu, Jin, Tang, Qi, Fang, Dong, Zhang, Lei, Gong, Yanqing, He, Qun, Gong, Kan, He, Zhisong, Wang, Gang, Li, Xuesong, Guo, Yinglu, Zhou, Liqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2015
Materias:	Moderated Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708675/ http://dx.doi.org/10.3978/j.issn.2223-4683.2015.s162

Ejemplares similares

AB121. The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy
por: Tang, Qi, et al.
Publicado: (2015)

AB93. Prognostic and predictive value of epigenetic biomarkers in upper tract urothelial carcinoma: a large-scale multi-gene promoter methylation analysis
por: Xiong, Gengyan, et al.
Publicado: (2014)

AB169. CCDC34 is up-regulated in bladder cancer and its silencing suppresses bladder cancer cell proliferation and migration
por: Gong, Yanqing, et al.
Publicado: (2015)

AB113. Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT3-4 diseases
por: Su, Xiaohong, et al.
Publicado: (2015)

AB90. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of methylation status
por: Zhang, Lei, et al.
Publicado: (2014)

AB122. Changing from open to laparoscopic surgery and medium-term prognosis of renal cell carcinoma patients with venous tumor thrombus: a single center study of 276 cases
por: Zhou, Liqun, et al.
Publicado: (2015)

AB133. Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high volume center of China
por: Xiong, Gengyan, et al.
Publicado: (2014)

AB92. Prevalence and factors associated with baseline chronic kidney disease in China: a 10-year study of 785 upper urinary tract urothelial carcinoma patients
por: Xiong, Gengyan, et al.
Publicado: (2014)

AB116. Research of efficacy of brachytherapy for localized prostate cancer
por: Wang, Tianyu, et al.
Publicado: (2015)

AB87. Evaluating the impact of preoperative anemia on the prognosis of upper tract urothelial carcinoma following radical nephroureterectomy
por: Xing, Yunchao, et al.
Publicado: (2014)

AB118. Feasibility and safety evaluation of pure laparoscopic radical nephrectomy and thrombectomy for renal tumor patients with venous tumor thrombus
por: Tang, Qi, et al.
Publicado: (2015)

Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients
por: Xiong, Gengyan, et al.
Publicado: (2018)

AB013. Retroperitoneal laparoscopic surgery for the upper urinary tract: the Institute of Urology, Peking University (IUPU) technique
por: Zhou, Liqun, et al.
Publicado: (2015)

Patient‐Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug Screening
por: Li, Zhichao, et al.
Publicado: (2021)

Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation
por: Zhang, Lei, et al.
Publicado: (2015)

Risk Factors for Unfavorable Pathological Types of Intravesical Recurrence in Patients With Upper Urinary Tract Urothelial Carcinoma Following Radical Nephroureterectomy
por: Zhu, Jun, et al.
Publicado: (2022)

AB063. Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT3-4 diseases
por: Su, Xiaohong, et al.
Publicado: (2016)

The Influence of Tumor Size on Oncologic Outcomes for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy
por: Su, Xiaohong, et al.
Publicado: (2016)

Comparison between completely and traditionally retroperitoneoscopic nephroureterectomy for upper tract urothelial cancer
por: Yao, Lin, et al.
Publicado: (2016)

Comparison of clinicopathologic characteristics, epigenetic biomarkers and prognosis between renal pelvic and ureteral tumors in upper tract urothelial carcinoma
por: Fang, Dong, et al.
Publicado: (2018)

Positive urinary fluorescence in situ hybridization indicates poor prognosis in patients with upper tract urothelial carcinoma
por: Guan, Bao, et al.
Publicado: (2018)

High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy
por: Shi, Bentao, et al.
Publicado: (2015)

Fluorescence in situ hybridization status of voided urine predicts invasive and high-grade upper tract urothelial carcinoma
por: Su, Xiaohong, et al.
Publicado: (2017)

Nomogram Predicting Renal Insufficiency after Nephroureterectomy for Upper Tract Urothelial Carcinoma in the Chinese Population: Exclusion of Ineligible Candidates for Adjuvant Chemotherapy
por: Fang, Dong, et al.
Publicado: (2014)

Role of lymph node dissection in the management of upper tract urothelial carcinomas: a meta-analysis
por: Guo, Runqi, et al.
Publicado: (2018)

AB91. Risk factors and treatment outcomes of new contralateral upper urinary urothelial carcinoma after nephroureterectomy: the experiences of a large Chinese center
por: Fang, Dong, et al.
Publicado: (2014)

AB110. The first prenatal diagnosis of von Hippel-Lindau syndrome in Chinese mainland
por: Peng, Shuanghe, et al.
Publicado: (2015)

AB175. The first large-scale study of VHL gene mutation spectrum and genotype-phenotype correlationship of VHL disease in China
por: Peng, Shuanghe, et al.
Publicado: (2015)

AB111. Features of Birt-Hogg-Dubé syndrome patients in East Asian countries
por: Li, Teng, et al.
Publicado: (2015)

AB109. Upper urinary stone management in China
por: Wang, Shaogang, et al.
Publicado: (2015)

AB174. VHL protein: a new therapeutic target of renal cell carcinoma
por: Wang, Jiangyi, et al.
Publicado: (2015)

AB107. Impact of variant differentiation on survival of patients with urothelial carcinoma of the bladder treated with radical
por: Ge, Peng, et al.
Publicado: (2015)

AB120. Early radical cystectomy in BCG naive pathological non-muscle invasive bladder cancer: results from a retrospective study with 164 cases
por: Hao, Han, et al.
Publicado: (2015)

AB181. Telomere shortening is associated with genetic anticipation in Chinese Von Hippel-Lindau disease families
por: Ning, Xianghui, et al.
Publicado: (2015)

The Evolution of Clinicopathological Diagnostic Features of Upper Tract Urothelial Carcinoma in China: A Summary of 2561 Cases in the Last 20 Years
por: Xu, Chunru, et al.
Publicado: (2022)

AB119. Clinical significance of residual tumors at repeat transurethral resection in patients with T1 bladder cancer
por: Chen, Jinchao, et al.
Publicado: (2015)

AB108. Renal arterial pseudoaneurysm and renal arteriovenous fistula following partial nephrectomy
por: Chen, Jinchao, et al.
Publicado: (2015)

AB114. Analyses of 77 multilocular cystic renal cell carcinoma cases from a single center
por: Li, Teng, et al.
Publicado: (2015)

Characteristics and treatment outcomes of pan-urothelial cell carcinoma: a descriptive analysis of 45 patients
por: Fang, Dong, et al.
Publicado: (2015)

AB180. The relationship between fructose-1, 6-bisphosphatase and hypoxia related genes expression in clear cell renal cell carcinoma
por: Ning, Xianghui, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vhm7okp687e3m9igv1b79kkfmd